MIRUM PHARMACEUTICALS INC (MIRM)
US6047491013 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -163.41M | -135.67M | -83.99M | -103.27M | -52.55M | |||
| Depreciation Amortization | 10.83M | 3.24M | 600.00K | 310.00K | 140.00K | |||
| Income Taxes - Deferred | 0.00 | -6.58M | N/A | N/A | N/A | |||
| Change In Working Capital | -22.64M | -21.05M | 16.98M | 610.00K | 7.12M | |||
| Interest Paid | 6.82M | N/A | N/A | N/A | N/A | |||
| Taxes Paid | 125.00K | N/A | 0.00 | 10.00K | N/A | |||
| Other non cash items | 104.28M | 39.92M | -66.35M | 13.28M | 5.93M | |||
| OPERATING CASH FLOW | -70.94M | -120.14M | -132.76M | -89.08M | -39.36M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -20.11M | -280.00K | -19.02M | -230.00K | -280.00K | |||
| Other Investing Activity | -87.09M | 7.98M | 67.57M | 38.10M | -127.50M | |||
| INVESTING CASH FLOW | -107.20M | 7.70M | 48.55M | 37.87M | -127.78M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 305.30M | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 227.15M | 114.64M | 9.01M | 131.87M | 127.18M | |||
| Other Financing Activity | -195.86M | -5.55M | 64.45M | 49.42M | N/A | |||
| FINANCING CASH FLOW | 336.60M | 109.09M | 73.47M | 181.29M | 127.18M | |||
| Exchange Rate Effect | -133.00K | 10.00K | 0.00 | 30.00K | -30.00K | |||
| CHANGE IN CASH | 158.32M | -3.34M | -10.74M | 130.11M | -39.99M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -70.94M | -120.14M | -132.76M | -89.08M | -39.36M | |||
| Capital Expenditure | -20.11M | -280.00K | -19.02M | -230.00K | -280.00K | |||
| FREE CASH FLOW | -91.05M | -120.42M | -151.78M | -89.31M | -39.64M | |||
All data in USD